Stryker ROA 2012-2025 | SYK
Current and historical return on assets (ROA) values for Stryker (SYK) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Stryker ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2025-09-30 | $2.94B | $47.06B | 6.46% |
| 2025-06-30 | $2.92B | $46.33B | 6.52% |
| 2025-03-31 | $2.86B | $46.01B | 6.65% |
| 2024-12-31 | $2.99B | $42.97B | 7.24% |
| 2024-09-30 | $3.59B | $43.83B | 8.85% |
| 2024-06-30 | $3.45B | $39.13B | 8.81% |
| 2024-03-31 | $3.36B | $39.40B | 8.69% |
| 2023-12-31 | $3.17B | $39.91B | 8.32% |
| 2023-09-30 | $2.59B | $38.04B | 6.93% |
| 2023-06-30 | $2.71B | $37.41B | 7.37% |
| 2023-03-31 | $2.63B | $36.83B | 7.21% |
| 2022-12-31 | $2.36B | $36.88B | 6.50% |
| 2022-09-30 | $2.46B | $35.98B | 6.88% |
| 2022-06-30 | $2.08B | $36.03B | 5.90% |
| 2022-03-31 | $2.02B | $36.14B | 5.81% |
| 2021-12-31 | $1.99B | $34.63B | 5.87% |
| 2021-09-30 | $1.90B | $34.15B | 5.60% |
| 2021-06-30 | $2.08B | $33.70B | 6.23% |
| 2021-03-31 | $1.41B | $33.46B | 4.28% |
| 2020-12-31 | $1.60B | $34.33B | 5.01% |
| 2020-09-30 | $1.76B | $32.29B | 5.69% |
| 2020-06-30 | $1.60B | $31.48B | 5.44% |
| 2020-03-31 | $2.16B | $29.44B | 7.69% |
| 2019-12-31 | $2.08B | $30.17B | 7.64% |
| 2019-09-30 | $3.43B | $26.66B | 12.91% |
| 2019-06-30 | $3.55B | $26.35B | 13.98% |
| 2019-03-31 | $3.52B | $25.94B | 14.55% |
| 2018-12-31 | $3.55B | $27.23B | 15.28% |
| 2018-09-30 | $1.24B | $22.08B | 5.62% |
| 2018-06-30 | $1.08B | $21.57B | 4.94% |
| 2018-03-31 | $1.02B | $22.13B | 4.68% |
| 2017-12-31 | $1.02B | $22.20B | 4.77% |
| 2017-09-30 | $1.78B | $21.49B | 8.50% |
| 2017-06-30 | $1.70B | $21.29B | 8.25% |
| 2017-03-31 | $1.69B | $20.52B | 8.27% |
| 2016-12-31 | $1.65B | $20.44B | 8.15% |
| 2016-09-30 | $1.66B | $20.19B | 8.66% |
| 2016-06-30 | $1.61B | $20.52B | 8.88% |
| 2016-03-31 | $1.62B | $19.67B | 9.42% |
| 2015-12-31 | $1.44B | $16.22B | 8.78% |
| 2015-09-30 | $1.18B | $15.92B | 7.07% |
| 2015-06-30 | $0.93B | $16.82B | 5.47% |
| 2015-03-31 | $0.67B | $16.58B | 3.90% |
| 2014-12-31 | $0.52B | $17.28B | 3.02% |
| 2014-09-30 | $0.64B | $17.52B | 3.85% |
| 2014-06-30 | $0.69B | $17.23B | 4.29% |
| 2014-03-31 | $0.77B | $16.16B | 5.05% |
| 2013-12-31 | $1.01B | $15.74B | 6.81% |
| 2013-09-30 | $0.89B | $14.88B | 6.29% |
| 2013-06-30 | $1.14B | $14.38B | 8.37% |
| 2013-03-31 | $1.25B | $14.09B | 9.57% |
| 2012-12-31 | $1.30B | $13.21B | 10.24% |
| 2012-09-30 | $1.43B | $12.78B | 11.51% |
| 2012-06-30 | $1.40B | $12.26B | 11.46% |
| 2012-03-31 | $1.39B | $12.46B | 11.50% |
| 2011-12-31 | $1.35B | $12.15B | 11.43% |
| 2011-09-30 | $1.24B | $12.08B | 10.82% |
| 2011-06-30 | $1.25B | $11.60B | 11.23% |
| 2011-03-31 | $1.26B | $11.23B | 11.71% |
| 2010-12-31 | $1.27B | $10.90B | 12.17% |
| 2010-09-30 | $1.28B | $10.77B | 12.84% |
| 2010-06-30 | $1.18B | $10.06B | 12.48% |
| 2010-03-31 | $1.15B | $10.10B | 12.92% |
| 2009-12-31 | $1.11B | $9.07B | 13.40% |
| 2009-09-30 | $1.08B | $8.46B | 13.67% |
| 2009-06-30 | $1.12B | $7.92B | 14.65% |
| 2009-03-31 | $1.14B | $7.59B | 14.80% |
| 2008-12-31 | $1.15B | $7.60B | 14.85% |
| 2008-09-30 | $1.15B | $7.58B | 14.94% |
| 2008-06-30 | $1.10B | $8.03B | 14.70% |
| 2008-03-31 | $1.07B | $7.75B | 15.01% |
| 2007-12-31 | $1.02B | $7.35B | 15.25% |
| 2007-09-30 | $0.97B | $6.86B | 15.38% |
| 2007-06-30 | $0.93B | $6.42B | 15.63% |
| 2007-03-31 | $0.87B | $6.08B | 15.57% |
| 2006-12-31 | $0.78B | $5.87B | 14.56% |
| 2006-09-30 | $0.73B | $5.40B | 14.21% |
| 2006-06-30 | $0.66B | $5.11B | 13.56% |
| 2006-03-31 | $0.63B | $4.99B | 13.48% |
| 2005-12-31 | $0.64B | $4.99B | 14.61% |
| 2005-09-30 | $0.60B | $4.40B | 14.43% |
| 2005-06-30 | $0.50B | $4.17B | 12.48% |
| 2005-03-31 | $0.47B | $4.07B | 12.39% |
| 2004-12-31 | $0.44B | $4.08B | 12.25% |
| 2004-09-30 | $0.44B | $3.58B | 13.00% |
| 2004-06-30 | $0.53B | $3.47B | 16.54% |
| 2004-03-31 | $0.49B | $3.23B | 15.71% |
| 2003-12-31 | $0.45B | $3.16B | 15.06% |
| 2003-09-30 | $0.43B | $2.98B | 14.54% |
| 2003-06-30 | $0.39B | $3.01B | 13.65% |
| 2003-03-31 | $0.37B | $2.92B | 13.35% |
| 2002-12-31 | $0.35B | $2.82B | 13.06% |
| 2002-09-30 | $0.32B | $2.72B | 12.43% |
| 2002-06-30 | $0.31B | $2.60B | 12.33% |
| 2002-03-31 | $0.29B | $2.46B | 11.77% |
| 2001-12-31 | $0.27B | $2.42B | 11.13% |
| 2001-09-30 | $0.26B | $2.41B | 10.71% |
| 2001-06-30 | $0.25B | $2.39B | 10.12% |
| 2001-03-31 | $0.23B | $2.41B | 9.40% |
| 2000-12-31 | $0.22B | $2.43B | 8.78% |
| 2000-09-30 | $0.20B | $2.54B | 7.76% |
| 2000-06-30 | $0.15B | $2.58B | 5.72% |
| 2000-03-31 | $0.09B | $2.56B | 3.50% |
| 1999-12-31 | $0.02B | $2.58B | 0.71% |
| 1999-09-30 | $-0.09B | $2.70B | -3.30% |
| 1999-06-30 | $-0.06B | $2.66B | -2.39% |
| 1999-03-31 | $-0.02B | $2.77B | -0.88% |
| 1998-12-31 | $0.04B | $2.89B | 2.68% |
| 1998-09-30 | $0.14B | $1.07B | 14.05% |
| 1998-06-30 | $0.14B | $1.02B | 13.83% |
| 1998-03-31 | $0.13B | $1.00B | 13.49% |
| 1997-12-31 | $0.13B | $0.99B | 13.09% |
| 1997-09-30 | $0.12B | $0.96B | 12.43% |
| 1997-06-30 | $0.11B | $0.94B | 12.08% |
| 1997-03-31 | $0.11B | $0.93B | 11.78% |
| 1996-12-31 | $0.10B | $0.99B | 11.42% |
| 1996-09-30 | $0.10B | $0.91B | 11.30% |
| 1996-06-30 | $0.10B | $0.87B | 11.12% |
| 1996-03-31 | $0.09B | $0.87B | 10.72% |
| 1995-12-31 | $0.09B | $0.86B | 10.47% |
| 1995-09-30 | $0.08B | $0.83B | 10.13% |
| 1995-06-30 | $0.08B | $0.84B | 10.05% |
| 1995-03-31 | $0.08B | $0.80B | 10.89% |
| 1994-12-31 | $0.07B | $0.77B | 11.72% |
| 1994-09-30 | $0.07B | $0.73B | 12.87% |
| 1994-06-30 | $0.07B | $0.49B | 14.42% |
| 1994-03-31 | $0.06B | $0.47B | 14.75% |
| 1993-12-31 | $0.06B | $0.45B | 15.08% |
| 1993-09-30 | $0.06B | $0.42B | 15.43% |
| 1993-06-30 | $0.05B | $0.37B | 15.89% |
| 1993-03-31 | $0.05B | $0.35B | 16.01% |
| 1992-12-31 | $0.05B | $0.34B | 16.13% |
| 1992-09-30 | $0.04B | $0.30B | 15.36% |
| 1992-06-30 | $0.04B | $0.28B | 15.07% |
| 1992-03-31 | $0.04B | $0.27B | 14.39% |
| 1991-12-31 | $0.03B | $0.27B | 13.87% |
| 1991-09-30 | $0.03B | $0.24B | 13.00% |
| 1991-06-30 | $0.04B | $0.22B | 17.54% |
| 1991-03-31 | $0.04B | $0.22B | 18.25% |
| 1990-12-31 | $0.03B | $0.21B | 18.55% |
| 1990-09-30 | $0.03B | $0.19B | 19.56% |
| 1990-06-30 | $0.02B | $0.17B | 14.13% |
| 1990-03-31 | $0.02B | $0.16B | 14.21% |
| 1989-12-31 | $0.02B | $0.15B | 14.26% |
| 1989-09-30 | $0.02B | $0.14B | 14.23% |
| 1989-06-30 | $0.02B | $0.14B | 14.12% |
| 1989-03-31 | $0.02B | $0.13B | 13.93% |
| 1988-12-31 | $0.02B | $0.13B | 13.65% |
| 1988-09-30 | $0.02B | $0.12B | 13.36% |
| 1988-06-30 | $0.01B | $0.11B | 13.02% |
| 1988-03-31 | $0.01B | $0.11B | 12.62% |
| 1987-12-31 | $0.01B | $0.11B | 13.20% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $139.118B | $22.595B |
| Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $211.725B | 24.40 |
| EssilorLuxottica (ESLOY) | France | $146.103B | 0.00 |
| Boston Scientific (BSX) | United States | $130.559B | 29.85 |
| Medtronic (MDT) | Ireland | $124.048B | 17.19 |
| Medline (MDLN) | United States | $57.961B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.907B | 0.00 |
| Agilent Technologies (A) | United States | $39.588B | 25.03 |
| ResMed (RMD) | United States | $37.591B | 26.02 |
| GE HealthCare Technologies (GEHC) | United States | $37.239B | 17.81 |
| Koninklijke Philips (PHG) | Netherlands | $28.483B | 18.60 |
| Terumo (TRUMY) | Japan | $20.476B | 23.05 |
| Insulet (PODD) | United States | $20.239B | 62.82 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.303B | 10.79 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.893B | 0.00 |
| Baxter (BAX) | United States | $10.338B | 8.34 |
| Sunny Optical Technology (SNPTF) | China | $9.589B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.457B | 30.41 |
| Demant (WILYY) | Denmark | $7.372B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $4.261B | 12.98 |
| Envista Holdings (NVST) | United States | $4.150B | 23.81 |
| BillionToOne (BLLN) | United States | $4.061B | 0.00 |
| ICU Medical (ICUI) | United States | $3.855B | 24.48 |
| Haemonetics (HAE) | United States | $3.378B | 15.04 |
| Prestige Consumer Healthcare (PBH) | United States | $3.131B | 14.28 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.099B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.255B | 14.50 |
| Perrigo (PRGO) | Ireland | $2.068B | 5.18 |
| Neogen (NEOG) | United States | $2.012B | 44.05 |
| LeMaitre Vascular (LMAT) | United States | $2.002B | 40.31 |
| AtriCure (ATRC) | United States | $1.942B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.805B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.678B | 73.55 |
| Phibro Animal Health (PAHC) | United States | $1.665B | 16.63 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.471B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.437B | 20.80 |
| Kestra Medical Technologies (KMTS) | United States | $1.333B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.176B | 348.86 |
| Capricor Therapeutics (CAPR) | United States | $1.113B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.062B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.002B | 0.00 |
| InMode (INMD) | Israel | $0.881B | 9.96 |
| Valneva SE (VALN) | France | $0.867B | 0.00 |
| Omeros (OMER) | United States | $0.852B | 0.00 |
| CeriBell (CBLL) | United States | $0.814B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.578B | 15.67 |
| Cerus (CERS) | United States | $0.499B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.479B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.458B | 0.00 |
| Brainsway (BWAY) | Israel | $0.454B | 77.27 |
| Canopy Growth (CGC) | Canada | $0.438B | 0.00 |
| Quanterix (QTRX) | United States | $0.346B | 0.00 |
| Evolus (EOLS) | United States | $0.337B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.279B | 22.21 |
| TriSalus Life Sciences (TLSI) | United States | $0.276B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.240B | 141.00 |
| TerrAscend (TSNDF) | Canada | $0.239B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.232B | 0.00 |
| High Tide (HITI) | Canada | $0.224B | 0.00 |
| Organigram Global (OGI) | Canada | $0.218B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Sanara MedTech (SMTI) | United States | $0.203B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.196B | 17.27 |
| Accendra Health (ACH) | United States | $0.195B | 1.95 |
| OraSure Technologies (OSUR) | United States | $0.193B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.192B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.158B | 0.00 |
| Apyx Medical (APYX) | United States | $0.153B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.149B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.146B | 0.00 |
| Fonar (FONR) | United States | $0.116B | 16.79 |
| Jushi Holdings (JUSHF) | United States | $0.114B | 0.00 |
| MacroGenics (MGNX) | United States | $0.109B | 0.00 |
| Exagen (XGN) | United States | $0.106B | 0.00 |
| Biote (BTMD) | United States | $0.106B | 4.64 |
| Sharps Technology (STSS) | United States | $0.069B | 0.00 |
| ImmuCell (ICCC) | United States | $0.058B | 24.46 |
| Nephros (NEPH) | United States | $0.048B | 34.46 |
| Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
| Veru (VERU) | United States | $0.043B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.038B | 0.00 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.031B | 15.67 |
| Jin Medical (ZJYL) | China | $0.024B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.023B | 0.00 |
| Bonk (BNKK) | United States | $0.018B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.015B | 0.00 |
| INLIF (INLF) | China | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.007B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |